Home | Contact us | Site map | Careers | Q&A | Advantages of Québec |
 Search
| 
 NEWS:
  SGF Profile  
  Investment Groups  
  Our Investments  
  Documentation Center  
 
By investment groups
 | 
By companies
 | 
By regions of Québec
  
 

Life Sciences

Agri-Food 

Chemicals, Energy, Environment 

Mines, Materials, Energy, Environment 

Forest Products 

Life Sciences 

Information and Communication Technologies 

 

 

Principal investments:
Life Sciences
  SGF's
Participation
  Shareholder(s)
Aeterna Zentaris 
Development of medication to fight cancer and other diseases
 

17%

  SGF
Solidarity Fund QFL, Other

Atrium Innovations  
Production and distribution of active ingredients

17%

SGF 
Aeterna Laboratories inc.
Solidarity Fund QFL
Private Investor
Fonds d’investissement bioalimentaire
Biotechnologies Océanova 
Production of active ingredients obtained from the St-Lawrence marine biomass

31%

SGF 
Atrium,
Bio-Innovation, Solidarity Fund QFL
Cryocath Technologies
Design and manufacture of cryogenic catheter ablation systems for the treatment of cardiovascular diseases
 

8% 

  SGF
Other
GeneChem Thérapeutiques
Venture capital fund specialized in research projects and companies involved in genomics
 

7%

  SGF
Fonds Bombardier, Shire Pharmaceutical, Solidarity Fund QFL
Médicago 

Manufacturing of recombinant proteins for pharmaceutical use

 

21%

  SGF
Other
Génopole Premier jour
Investment Fund
 

6% 

  SGF
CDC Entreprises, Groupe Industriel Marcel Dassault, FSTQ
ORTHOsoft
Develops and markets medical navigation software for the global orthopedics market

19%

SGF
Public

Warnex
Specialized analytical, bioanalytical, and medical laboratories services and Rapid food pathogen detection system.

 

18%

  SGF
Public


Home  |  Legal Notice  |  Corporate Policies  | 

 Copyright © SGF 2007